627 related articles for article (PubMed ID: 30226595)
1. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
2. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
3. Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.
Simova J; Sapega O; Imrichova T; Stepanek I; Kyjacova L; Mikyskova R; Indrova M; Bieblova J; Bubenik J; Bartek J; Hodny Z; Reinis M
Oncotarget; 2016 Aug; 7(34):54952-54964. PubMed ID: 27448982
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
[TBL] [Abstract][Full Text] [Related]
5. STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells.
Mikyskova R; Sapega O; Psotka M; Novotny O; Hodny Z; Balintova S; Malinak D; Svobodova J; Andrys R; Rysanek D; Musilek K; Reinis M
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36825563
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
[TBL] [Abstract][Full Text] [Related]
7. T-helper-1-cell cytokines drive cancer into senescence.
Braumüller H; Wieder T; Brenner E; Aßmann S; Hahn M; Alkhaled M; Schilbach K; Essmann F; Kneilling M; Griessinger C; Ranta F; Ullrich S; Mocikat R; Braungart K; Mehra T; Fehrenbacher B; Berdel J; Niessner H; Meier F; van den Broek M; Häring HU; Handgretinger R; Quintanilla-Martinez L; Fend F; Pesic M; Bauer J; Zender L; Schaller M; Schulze-Osthoff K; Röcken M
Nature; 2013 Feb; 494(7437):361-5. PubMed ID: 23376950
[TBL] [Abstract][Full Text] [Related]
8. [Induction of robust senescence-associated secretory phenotype in mouse NIH-3T3 cells by mitomycin C].
Huang WX; Guo XX; Peng ZZ; Weng CL; Huang CY; Shi BY; Yang J; Liao XX; Li XY; Zheng HL; Liu XG; Sun XR
Sheng Li Xue Bao; 2017 Feb; 69(1):33-40. PubMed ID: 28217805
[TBL] [Abstract][Full Text] [Related]
9. TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect.
Penafuerte C; Galipeau J
Cancer Immunol Immunother; 2008 Aug; 57(8):1197-206. PubMed ID: 18214474
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea-induced senescent peripheral blood mesenchymal stromal cells inhibit bystander cell proliferation of JAK2V617F-positive human erythroleukemia cells.
Bjelica S; Diklić M; Đikić D; Kovačić M; Subotički T; Mitrović-Ajtić O; Radojković M; Čokić VP; Santibanez JF
FEBS J; 2019 Sep; 286(18):3647-3663. PubMed ID: 31090259
[TBL] [Abstract][Full Text] [Related]
11. IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine 'bystander senescence'.
Hubackova S; Krejcikova K; Bartek J; Hodny Z
Aging (Albany NY); 2012 Dec; 4(12):932-51. PubMed ID: 23385065
[TBL] [Abstract][Full Text] [Related]
12. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
Nagesh PKB; Chowdhury P; Hatami E; Kumari S; Kashyap VK; Tripathi MK; Wagh S; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38537-38554. PubMed ID: 31553876
[TBL] [Abstract][Full Text] [Related]
13. Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents.
Bojko A; Czarnecka-Herok J; Charzynska A; Dabrowski M; Sikora E
Cells; 2019 Nov; 8(12):. PubMed ID: 31771226
[TBL] [Abstract][Full Text] [Related]
14. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
16. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell escape from therapy-induced senescence.
Saleh T; Tyutyunyk-Massey L; Murray GF; Alotaibi MR; Kawale AS; Elsayed Z; Henderson SC; Yakovlev V; Elmore LW; Toor A; Harada H; Reed J; Landry JW; Gewirtz DA
Biochem Pharmacol; 2019 Apr; 162():202-212. PubMed ID: 30576620
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Translocation of Argonaute 2 in Cytokine-Induced Senescence.
Rentschler M; Chen Y; Pahl J; Soria-Martinez L; Braumüller H; Brenner E; Bischof O; Röcken M; Wieder T
Cell Physiol Biochem; 2018; 51(3):1103-1118. PubMed ID: 30476917
[TBL] [Abstract][Full Text] [Related]
19. A chemotherapy-associated senescence bystander effect in breast cancer cells.
Di X; Bright AT; Bellott R; Gaskins E; Robert J; Holt S; Gewirtz D; Elmore L
Cancer Biol Ther; 2008 Jun; 7(6):864-72. PubMed ID: 18340112
[TBL] [Abstract][Full Text] [Related]
20. IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.
Hubackova S; Kucerova A; Michlits G; Kyjacova L; Reinis M; Korolov O; Bartek J; Hodny Z
Oncogene; 2016 Mar; 35(10):1236-49. PubMed ID: 25982278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
